Showing results (211-220 of 249) with videos related to
Sort By:
Pageof 25
Cancer Immunology Research|July 4, 2019
MERTK Acts as a Costimulatory Receptor on Human CD8+ T CellsMarlies J W Peeters, Donata Dulkeviciute, Arianna Draghi, et al.Carcinogenesis|January 6, 2012
MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cellsCristina Garrido, Laura Paco, Irene Romero, et al.Human Immunology|August 7, 2007
High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancerJose M Cozar, Jose M Romero, Natalia Aptsiauri, et al.Immunogenetics|August 27, 2018
HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15María A Garrido, Teresa Rodriguez, Svitlana Zinchenko, et al.Advanced Healthcare Materials|November 4, 2021
Modeling Metastatic Colonization in a Decellularized Organ Scaffold-Based Perfusion BioreactorMaria Rafaeva, Edward R Horton, Adina R D Jensen, et al.Human Immunology|December 8, 2009
Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patientsPablo Sáenz-López, Rafael Carretero, Fernando Vazquez, et al.International Journal of Cancer|October 28, 2016
The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltrationFrancisco Perea, Mónica Bernal, Abel Sánchez-Palencia, et al.Oncotarget|August 27, 2019
Expression and function of Kv1.3 channel in malignant T cells in Sézary syndromeTengpeng Hu, Terkild Brink Buus, Thorbjørn Krejsgaard, et al.Cancer Research|June 29, 2017
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ SignalingMarco Donia, Katja Harbst, Marit van Buuren, et al.Immunogenetics|May 18, 2006
LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomasIsabel Maleno, Jose Maria Romero, Teresa Cabrera, et al.Pageof 25